Aurisco Pharmaceutical Co., Ltd. (605116)
SSE SSE Primary Summary
605116 Chart
People also search for
Aurisco Pharmaceutical Co., Ltd. (605116) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Aurisco Pharmaceutical Co., Ltd. ever had a stock split?
Aurisco Pharmaceutical Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Dingjun Chu CEO | SSE Exchange | CNE1000042S4 ISIN |
| CN Country | 1,521 Employees | 15 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Overview
Aurisco Pharmaceutical Co., Ltd., established in 1998 and headquartered in Tiantai, China, is a prominent player in the global pharmaceutical market. The company is dedicated to the research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (APIs), and formulations. Aurisco Pharmaceutical serves a diverse range of therapeutic areas, including respiratory, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health, catering to a broad clientele worldwide. Besides its core offerings, the company also specializes in providing contract manufacturing services and related development works for chemicals, intermediates, and APIs, positioning itself as a comprehensive service provider in the pharmaceutical industry.
Products and Services
- Dexamethasone: Used for treating various skin diseases.
- Fluticasone Propionate Preparations: Aimed at treating asthma and allergic rhinitis.
- Fluticasone Furoate Preparations: Used for the treatment of asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD).
- Eplerenone Preparations: Utilized in the management of hypertension and heart failure.
- Bepedalic Acid Preparations: Designed for treating hypercholesterolemia or atherosclerotic cardiovascular diseases.
- Tenofovir: Used in the treatment of HIV-1 infection and chronic hepatitis B.
- Pregabalin Preparations: Aimed at the treatment of neuropathic pain, fibromyalgia, epilepsy, and other conditions.
- Brivaracetam Preparations: Used for treating epilepsy.
- Abiraterone Acetate Preparation: Utilized in the treatment of prostate cancer.
- Enzalutamide Preparation: Another preparation for the treatment of prostate cancer.
- Dydrogesterone Preparations: Used to treat conditions like dysmenorrhea, endometriosis, and irregular menstrual cycles among others.
Furthermore, Aurisco Pharmaceutical provides high-quality contract manufacturing services, which include the development and manufacturing of chemicals, intermediates, and APIs. This extensive range of services and products underscores the company’s commitment to supporting global healthcare needs.
